(19)
(11) EP 4 031 922 A1

(12)

(43) Date of publication:
27.07.2022 Bulletin 2022/30

(21) Application number: 20876361.5

(22) Date of filing: 19.10.2020
(51) International Patent Classification (IPC): 
G02B 21/00(2006.01)
G01N 33/533(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 21/6458; G02B 21/245; G02B 27/34
(86) International application number:
PCT/US2020/056302
(87) International publication number:
WO 2021/077075 (22.04.2021 Gazette 2021/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.10.2019 US 201916658052
19.03.2020 US 202016824632

(71) Applicant: Sequlite Genomics US, Inc.
Dublin, CA 94568 (US)

(72) Inventors:
  • CHE, Diping
    San Ramon, CA 94582 (US)
  • CHE, James
    San Ramon, CA 94582 (US)

(74) Representative: Inchingalo, Simona 
Bugnion S.p.A. Viale Lancetti, 17
20158 Milano
20158 Milano (IT)

   


(54) VIRTUAL FIDUCIALS